October 31, 2014: It’s Halloween at last! In the final installment of BioSpace’s spooky-themed features, we decided to go right to the top—to the C-level suite, in fact. This is our look at some of the biotech companies that said “Off with their heads!” to their executives this year...
October 24, 2014: In our third Halloween-themed feature, we took a lighthearted look at the ghoul and the fairy godmother of the biotech industry: The FDA. Nothing can make industry executives feel more frightened—or enlightened—than a solid decision from these regulators!
October 14, 2014: Next, we take a look at some of the biggest Biotech Zombies. A “zombie company” is media parlance for a firm that either exists solely on government or venture capital bailouts to exist, or a heavily indebted company that is able to repay the interest on its debts but not reduce its debts.
October 8, 2014: BioSpace is in the Halloween spirit and we look at some Vampire Venture Capitalists: Activist investor-run funds that have wielded their influence inside the boardroom to get as much value out of a company before either selling it or exiting for massive returns on their original investment.